“MET-Mediated Drug Resistance in Colorectal Cancer: In Silico Analysis of the Potential of Epicatechin-3-Gallate and Epigallocatechin-3-Gallate as Therapeutic Adjuvants” (2026) Integrated Health Research Journal, 3((1-Supp), pp. 05–16. doi:10.47963/ihrj.v3i(1-Supp).2075.